5 news items
Viatris to Participate in the Jeffries Global Healthcare Conference
VTRS
31 May 24
the world annually and touching all of life's moments, from birth to the end of life, acute conditions to chronic diseases. With our exceptionally
Viatris to Participate in the BofA Securities 2024 Health Care Conference
VTRS
2 May 24
billion patients around the world annually and touching all of life's moments, from birth to the end of life, acute conditions to chronic diseases
Viatris to Report First Quarter 2024 Financial Results on May 9, 2024
VTRS
16 Apr 24
to the end of life, acute conditions to chronic diseases. With our exceptionally extensive and diverse portfolio of medicines, a one-of-a-kind global
Viatris Announces Launch of First Bioequivalent Generic Version of Copaxone® 20 mg/mL Once-Daily in Canada
VTRS
15 Apr 24
), a chronic inflammatory disease of the central nervous system.
Viatris Canada's Country Manager
Viatris Hosts R&D Event Focusing on its Collaboration with Idorsia, Phase 3 Assets Selatogrel and Cenerimod and Key Elements of its Pipeline
VTRS
27 Mar 24
the potential to be a differentiated therapy for the treatment of Systemic Lupus Erythematosus (SLE), a chronic and progressive autoimmune disease
- Prev
- 1
- Next